Bexa

Bexa is a new, FDA-cleared 510(k) medical device that employs high resolution elastography to produce a map of abnormal breast tissues and masses.

Founded 2017
Investment year 2021
Invested through AB Segulah
CEO Joe Peterson
Chairperson Joe Peterson
Head Offices Rolling Hills Estates, CA, USA
SMA Board Representation Gabriel Urwitz